JAMOL

This brand name is authorized in Nigeria.

Active ingredients

The drug JAMOL contains one active pharmaceutical ingredient (API):

1	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1086	Eye drops	JAMOL EYE DROPS SOL_DROPS 0.5% 1 X 10	91 RNW-PP-136442 JAMOL EYE DROPS TIMOLOL MALEATE EQV TO TIMOLOL 0.5% W/V Timolol Maleate Eqv. to Timolol 0.5%w/v; Benzalkonium Chloride 0.01%w/v (as preservative) a4-1086 Drugs Imported Products 1 10 Prescription Only Medicine (POM) 6/23/2020 JUBILEE & ASSOCIATES L, , DOCEMO STREET LAGOS LAGOS 9097262533 jubileeandassociate@gmail.com ALPHA LABORATORIES LTD., 33/2.PIGDAMBER, A.B,-453 446 DISST.INDORE.(M.P.) INDIA, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED01	Timolol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1086